ArticleAnnals of African medicine2025
Hepatoprotective Activity of Red Ginger Extract on Acetaminophen-induced Liver Injury Models in HepG2 Cells.
Article in Annals of African medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe liver is a major organ that plays a crucial role in detoxifying drugs; however, exposure to hepatotoxic drugs can lead to liver damage. Some research indicates that Zingiber officinale , commonly known as red ginger, possesses various biological properties. The objective of this study was to examine the hepatoprotective effect of red ginger extract (RGE) against acetaminophen (APAP)-induced HepG2 cells. MATERIALS AND
methodsHepG2 cells were induced with APAP to simulate liver injury and subsequently treated with RGE. Levels of nitric oxide (NO) and lactate dehydrogenase (LDH) were measured using a colorimetric assay, while the levels of interleukin (IL)-6, IL-1β, and IL-10 were measured using an enzyme-linked immunosorbent assay. Gene expression of caspase-3 (Casp-3), Casp-9, and c-Jun kinase (JNK) was assessed by quantitative real-time polymerase chain reaction.
resultsAPAP-induced HepG2 cells exhibited a noticeable increase in pro-inflammatory markers. Cells treated with RGE showed lower levels of IL-1β and IL-6, and higher levels of IL-10 compared to the positive control. RGE treatment also reduced NO and LDH levels and downregulated the expression of Casp-3, Casp-9, and JNK genes.
conclusionsThese results indicate that RGE exerts hepatoprotective effects through increased IL-10 production, alongside the suppression of NO, IL-1β, IL-6, as well as Casp-3, Casp-9, and JNK gene expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.